Location History:
- Mölndal, SE (2006)
- Molndal, SE (2006)
- Askim, SE (2008 - 2021)
Company Filing History:
Years Active: 2006-2021
Title: Fritiof Pontén: Innovator in Cardiac Arrhythmia Treatment
Introduction
Fritiof Pontén is a notable inventor based in Askim, Sweden. He has made significant contributions to the field of medicine, particularly in the treatment of cardiac arrhythmias. With a total of three patents to his name, Pontén's work has the potential to impact many lives.
Latest Patents
Pontén's latest patents include innovative compounds aimed at treating cardiac arrhythmias. One of his notable inventions is related to oxabispidine compounds, which are useful in the prophylaxis and treatment of arrhythmias, specifically atrial and ventricular arrhythmias. Another significant patent involves 3,7-diazabicyclo[3.3.0]octanes, which also serve a similar purpose in managing cardiac arrhythmias.
Career Highlights
Throughout his career, Fritiof Pontén has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Quretech Bio AB. His experience in these organizations has allowed him to develop and refine his innovative ideas.
Collaborations
Pontén has collaborated with several professionals in his field, including Gert Strandlund and Peder Svensson. These partnerships have likely contributed to the success of his inventions and patents.
Conclusion
Fritiof Pontén's work in developing treatments for cardiac arrhythmias showcases his dedication to medical innovation. His patents reflect a commitment to improving patient care and advancing the field of cardiology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.